Related Experiment Video
Updated: Aug 16, 2026

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
Published on: March 30, 2022
A small compound that inhibits tumor necrosis factor-alpha-induced matrix metalloproteinase-9 upregulation
Ha Young Lee1, Kyoung Sun Park, Mi-Kyoung Kim
1Medical Research Center for Cancer Molecular Therapy and Department of Biochemistry, College of Medicine, Dong-A University, Busan 602-714, Republic of Korea.
Abstract:
Matrix metalloproteinase-9 (MMP-9) is critically involved in the tumor invasion and metastasis processes. Since TNF-alpha plays a crucial role in the regulation of MMP-9 expression, the development of molecules capable of modulating TNF-alpha-induced signaling is an issue of concern. We identified a novel synthetic compound that inhibits TNF-alpha-induced MMP-9 upregulation in the HT1080 human fibrosarcoma cell line. The active compound SM-7368 inhibited TNF-alpha-induced MMP-9 upregulation in a concentration-dependent manner and showed maximal activity at 10 microM. SM-7368 inhibited TNF-alpha-induced MMP-9 mRNA transcript accumulation and protein expression. We also found that SM-7368 strongly inhibits TNF-alpha-induced NF-kappaB activity but not AP-1 activity. Moreover, we found that SM-7368 strongly inhibits the TNF-alpha-induced invasion of HT1080 human fibrosarcoma cell line. Taken together, our results demonstrate that SM-7368 is a synthetic compound that inhibits TNF-alpha-induced MMP-9 expression, and thus SM-7368 should be useful for the development of chemotherapies targeting TNF-alpha-mediated tumor invasion and metastasis.
Insights
A novel compound, SM-7368, effectively inhibits tumor cell invasion by blocking tumor necrosis factor-alpha (TNF-alpha)-induced matrix metalloproteinase-9 (MMP-9) expression and activity.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Matrix metalloproteinase-9 (MMP-9) is crucial for tumor invasion and metastasis.
- Tumor necrosis factor-alpha (TNF-alpha) significantly regulates MMP-9 expression.
- Targeting TNF-alpha signaling pathways is a key strategy for cancer therapy.
Purpose of the Study:
- To identify and characterize novel synthetic compounds that inhibit TNF-alpha-induced MMP-9 expression.
- To evaluate the efficacy of SM-7368 in blocking cancer cell invasion.
- To elucidate the molecular mechanisms underlying SM-7368's anti-cancer activity.
Main Methods:
- HT1080 human fibrosarcoma cell line was used for in vitro studies.
- SM-7368's effect on TNF-alpha-induced MMP-9 upregulation was assessed at mRNA and protein levels.
- NF-kappaB and AP-1 activity assays were performed to determine the signaling pathways affected.
- Cell invasion assays were conducted to evaluate the functional impact of SM-7368.
Main Results:
- SM-7368 demonstrated potent, dose-dependent inhibition of TNF-alpha-induced MMP-9 upregulation, with maximal activity at 10 microM.
- SM-7368 suppressed both MMP-9 mRNA transcript accumulation and protein expression.
- The compound strongly inhibited TNF-alpha-induced NF-kappaB activity, but not AP-1 activity.
- SM-7368 significantly reduced the invasive potential of HT1080 cells in vitro.
Conclusions:
- SM-7368 is a novel synthetic compound that effectively inhibits TNF-alpha-induced MMP-9 expression and activity.
- SM-7368 targets the NF-kappaB signaling pathway, a key mediator of MMP-9 upregulation.
- These findings suggest SM-7368 holds promise for developing novel chemotherapies against TNF-alpha-mediated tumor invasion and metastasis.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
TGF - β Signaling Pathway
The Tumor Microenvironment